3431 - 3440 of 6560 Results
Title
Year
-
OPENTitle: Cardiac sympathetic denervation and anxiety in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 124Issue #:Start Page: 106997End Page: 106997Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106997Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11893108/pdf/nihms-2058597.pdfCitation Count: 8
-
OPENTitle: Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesiaJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 115Issue #: 3Start Page: 1713End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00868.2015Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4809970Citation Count: 26
-
OPENTitle: Use of Amplified Lewy Body Dementia Fibrils and Autoradiography to Characterize Binding of Radioligand Tg-1-90B to Alpha-Synuclein Fibrils in Postmortem Brain TissueJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 18Start Page: 1477End Page: 1477Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14181477Best OA location URL: https://www.mdpi.com/2073-4409/14/18/1477/pdf?version=1758535757Citation Count: 1
-
OPENTitle: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and DiseaseJournal Name: ReceptorsPublisher: MDPI AGVol: 3Issue #: 2Start Page: 155End Page: 181Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/receptors3020009Best OA location URL: https://www.mdpi.com/2813-2564/3/2/9/pdf?version=1712907165Citation Count: 45
-
OPENTitle: Intra‐ and inter‐network functional alterations in Parkinson's disease with mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 3Start Page: 1702End Page: 1715Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23499Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6866883Citation Count: 67
-
OPENTitle: Biochemical signatures of skin α-synuclein in synucleinopathies revealed by RT-QuIC assay end-product analysisJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 151Issue #: 1Start Page: 3End Page: 3Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-025-02973-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-025-02973-5.pdfCitation Count: 3
-
OPENTitle: Prevalence of REM sleep behavior disorder in Sun City, ArizonaJournal Name: HeliyonPublisher: Elsevier BVVol: 6Issue #: 1Start Page: e03140End Page: e03140Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e03140Best OA location URL: http://www.cell.com/article/S2405844019367994/pdfCitation Count: 16
-
OPENTitle: Speech Impairment in Early Parkinson’s Disease Is Associated with Nigrostriatal Dopaminergic DysfunctionJournal Name: Journal of Clinical MedicinePublisher: MDPI AGVol: 15Issue #: 3Start Page: 1006End Page: 1006Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/jcm15031006Best OA location URL: https://www.mdpi.com/2077-0383/15/3/1006/pdfCitation Count: 0
-
OPENTitle: Retrospective longitudinal analysis of blood microRNA-7-5p as a possible progression biomarker in people with Parkinson’s diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 20Issue #:Start Page: 1784013End Page: 1784013Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2026.1784013Best OA location URL: https://public-pages-files-2025.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1784013/pdfCitation Count: 0
- Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies2026OPENTitle: Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261463936End Page: 1877718X261463936Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261463936Citation Count: 0